Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Journal of the American Medical Directors Association
|
July 3, 2020
Rates of PRN Medication Administration in Australian Residential Aged Care
Leonie Picton, Jenni Ilomäki, Claire S Keen, et al.
Journal of the American Geriatrics Society
|
September 5, 2024
The cost of potentially inappropriate medications for older adults in Canada: A comparative cross-sectional study
Jean-François Huon, Chiranjeev Sanyal, Camille L Gagnon, et al.
BMJ Quality & Safety
|
May 24, 2024
What do clinical practice guidelines say about deprescribing? A scoping review
Aili Veronica Langford, Imaan Warriach, Aisling M McEvoy, et al.
JAMA Network Open
|
July 25, 2024
Reducing Central Nervous System-Active Medications to Prevent Falls and Injuries Among Older Adults: A Cluster Randomized Clinical Trial
Elizabeth A Phelan, Brian D Williamson, Benjamin H Balderson, et al.
Expert Review of Clinical Pharmacology
|
May 13, 2024
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
Emily G McDonald, Carina Lundby, Wade Thompson, et al.
Australasian Journal on Ageing
|
February 26, 2026
Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi Study
Amanda J Cross, Madiha Chaudhry, Darshna Goordeen, et al.
Journal of the American Medical Directors Association
|
July 1, 2024
Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities
Brigid E McInerney, Amanda J Cross, Christopher P Alderman, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Journal of the American Medical Directors Association
|
July 3, 2020
Rates of PRN Medication Administration in Australian Residential Aged Care
Leonie Picton, Jenni Ilomäki, Claire S Keen, et al.
Journal of the American Geriatrics Society
|
September 5, 2024
The cost of potentially inappropriate medications for older adults in Canada: A comparative cross-sectional study
Jean-François Huon, Chiranjeev Sanyal, Camille L Gagnon, et al.
BMJ Quality & Safety
|
May 24, 2024
What do clinical practice guidelines say about deprescribing? A scoping review
Aili Veronica Langford, Imaan Warriach, Aisling M McEvoy, et al.
JAMA Network Open
|
July 25, 2024
Reducing Central Nervous System-Active Medications to Prevent Falls and Injuries Among Older Adults: A Cluster Randomized Clinical Trial
Elizabeth A Phelan, Brian D Williamson, Benjamin H Balderson, et al.
Expert Review of Clinical Pharmacology
|
May 13, 2024
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
Emily G McDonald, Carina Lundby, Wade Thompson, et al.
Australasian Journal on Ageing
|
February 26, 2026
Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi Study
Amanda J Cross, Madiha Chaudhry, Darshna Goordeen, et al.
Journal of the American Medical Directors Association
|
July 1, 2024
Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities
Brigid E McInerney, Amanda J Cross, Christopher P Alderman, et al.
Page
of 6